Division of Nephrology, Kanazawa University Hospital, Kanazawa, Ishikawa, Japan.
Department of Nephrology, Kanazawa Medical University School of Medicine, Uchinada, Kahoku, Ishikawa, Japan.
BMJ Open. 2019 Jun 16;9(6):e023259. doi: 10.1136/bmjopen-2018-023259.
Recurrent acute kidney injury (AKI) is a recognised risk factor for mortality. However, it is unclear whether the period until AKI recurrence may have a major factor on patient outcome or not. To explore this issue, we (1) framed the hypothesis that early recurrence increases the risk of mortality and (2) evaluated the prognosis of recurrent AKI cases by setting 21 days as the cut-off period.
All studied cases were admitted and followed up at the Kanazawa University Hospital (Kanazawa, Japan) between 1 November 2006 and 31 October 2007. In total, 21 939 patients were retrospectively evaluated in their recurrences of AKI for 2 years and followed up until 31 October 2016. Risks for death were evaluated by the recurrences of AKI (Analysis 1). Patients who developed AKI recurrence before 21 days were defined as the early-recurrence group and the remaining cases as the late-recurrence group. Risks for death were evaluated by the two groups (Analysis 2).
510 patients (2.3%) developed the first AKI. Of these, 151 developed recurrent AKI within 2 years. The number of early-recurrence cases was 44 and that of non-recurrence or late-recurrence was 357. A total of 196 cases (38.4%) died, and higher risk for death was observed in the recurrent AKI group (Analysis 1; p=0.015, log-rank test). We found that the rate of all-cause mortality was higher in the early-recurrence group involving 33.8 deaths per 100 person-years, whereas the non-recurrence or late-recurrence group included only 6.2 deaths per 100 person-years (Analysis 2; p<0.001, log-rank test).
Patients experiencing recurrent AKI before 21 days from the first AKI clearly showed a relatively poor prognosis. Evidently, careful follow-up for at least 21 days after AKI would be highly useful to detect a recurrence event, possibly leading to a better prognosis after AKI.
复发性急性肾损伤(AKI)是公认的死亡危险因素。然而,AKI 复发的时间是否对患者预后有重大影响尚不清楚。为了探讨这一问题,我们(1)提出假说,即早期复发增加死亡风险,(2)通过将 21 天设为截止时间来评估复发性 AKI 病例的预后。
所有研究病例均于 2006 年 11 月 1 日至 2007 年 10 月 31 日在金泽大学医院(金泽,日本)住院并接受随访。共有 21939 例患者在 2 年内出现 AKI 复发,并随访至 2016 年 10 月 31 日。通过 AKI 的复发情况评估死亡风险(分析 1)。将在 21 天内发生 AKI 复发的患者定义为早期复发组,其余患者为晚期复发组。通过两组评估死亡风险(分析 2)。
510 例患者(2.3%)发生首次 AKI。其中,151 例在 2 年内发生复发性 AKI。早期复发病例数为 44 例,非复发或晚期复发病例数为 357 例。共有 196 例(38.4%)死亡,复发性 AKI 组的死亡风险更高(分析 1;p=0.015,对数秩检验)。我们发现,早期复发组的全因死亡率较高,为每 100 人年 33.8 例死亡,而非复发或晚期复发组仅为每 100 人年 6.2 例死亡(分析 2;p<0.001,对数秩检验)。
首次 AKI 后 21 天内发生复发性 AKI 的患者预后明显较差。显然,在 AKI 后至少 21 天进行密切随访,有助于发现复发事件,可能改善 AKI 后的预后。